Company news
Oncopeptides Ab (OMXSTO:ONCO) news
Oncopeptides Ab news releases on 6ix. Latest, May 26, 2026: Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti…
Press releases & updates
Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti in Central and Eastern Europe
May 26, 2026
Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs
May 20, 2026
Oncopeptides secures regulatory approval to start Window-of-Opportunity study in glioblastoma from Norwegian authorities
May 19, 2026
Oncopeptides publishes Q1 report 2026
May 13, 2026
Oncopeptides intends to submit type II variation to expand Pepaxti label to include third line treatment
May 11, 2026
Invitation to presentation of the Q1 report 2026
May 6, 2026
Oncopeptides publishes the 2025 Annual Report
April 28, 2026